Kyntra Bio (KYNB) Operating Margin (2014 - 2026)

Kyntra Bio has disclosed Operating Margin across 13 years of filings, most recently posting 1192.27% for Q2 2026.

• In Q2 2026, Operating Margin fell 29820.0% year-over-year to 1192.27%; the TTM figure through Jun 2026 stood at 665.1% (up 44854.0% YoY), while the FY2025 annual figure was 712.66%, down 20485.0% from the prior year.
• Operating Margin came in at 1192.27% for Q2 2026 at Kyntra Bio, down from 369.66% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 128.84% in Q4 2023 to a low of 38773.98% in Q3 2024.
• Average Operating Margin over 5 years is 2810.8%, with a median of 436.27% recorded in 2026.
• Year-over-year, Operating Margin tumbled 3861581 bps in 2024 and surged 3827110 bps in 2025.
• Over 5 years, Operating Margin stood at 787.52% in 2022, then jumped by 116 bps to 128.84% in 2023, then slumped by 277 bps to 227.53% in 2024, then slumped by 365 bps to 1058.1% in 2025, then fell by 13 bps to 1192.27% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 1192.27% in Q2 2026, 369.66% in Q1 2026, and 1058.1% in Q4 2025.